LC-MS/MS method development of aflibercept using Fab-selective proteolysis nSMOL technology
Postery | 2020 | ShimadzuInstrumentace
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
ZaměřeníKlinická analýza
VýrobceShimadzu
Klíčová slovaflstltidgvtr, iiwdsr, tegr, tnylthr, aflibercept, structure, peptide, fpldtlipdgk, fpldtlipdgkr, gek, gfiisnatyk, hqhk, hqhkk, lvnr, pfvemyseipeiihm, qtntiidvvlspshgielsv, sdtgrpfvemyseipeiihm, telnvgidfnweypssk, tqsgsemk, tqsgsemkk, vegf, region, nsmol, quantitation, immobilized, gas, trypsin, atvnghlykt, gielsvgekl, glytcaassg, iidvvlspsh, lkkfpldtli, lmtkknstfv, nvgidfnwey, nylthrqtnt, pdgkriiwds, proteolyzed, psskhqhkkl, rkgfiisnat, rvhekdktht, rvtspnitvt, sdtgrpfvem, semkkflstl, tegrelvipc, tidgvtrsdq, vlnctartel, vnrdlktqsg, ykeiglltce, yseipeiihm, kalpapiekt
Podobná PDF
Shimadzu Solutions for Biopharmaceutical - Application Notebook
2018|Shimadzu|Příručky
C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…
Klíčová slova
acid, acidamino, aminoantibody, antibodyglycan, glycannsmol, nsmolerexim, ereximstructure, structurenews, newsaggregates, aggregatesanalysis, analysismrm, mrmnucleic, nucleicglycans, glycanssizer, sizeraggregate
LCMS™ Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis -
2020|Shimadzu|Aplikace
Application News No. C216 nSMOL Antibody BA Kit LCMS™ Bioanalysis of Antibody Drugs Using FabSelective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis - Introduction - Immunological Mechanism of Application of LC-MS to Analysis of Antibody Tocilizumab is…
Klíčová slova
tocilizumab, tocilizumabnsmol, nsmolantibody, antibodystructure, structurediseases, diseasesprotocol, protocoltrypsin, trypsinconfirmation, confirmationmedical, medicaldrugs, drugsvalidation, validationinflammatory, inflammatorytreatment, treatmentaccuracy, accuracyvtmlr
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E116B Application News No. C145B nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables selective proteolysis…
Klíčová slova
nsmol, nsmoltrastuzumab, trastuzumabantibody, antibodystructure, structurepeptide, peptideconfirmation, confirmationaccuracy, accuracynsmoltm, nsmoltmquantitation, quantitationiyptngytr, iyptngytrcdr, cdrproteolysis, proteolysislcms, lcmsmrm, mrmfab
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis
2021|Shimadzu|Aplikace
LAAN-A-LM-E116B Application News No. C145B nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables selective proteolysis…
Klíčová slova
nsmol, nsmoltrastuzumab, trastuzumabantibody, antibodystructure, structureconfirmation, confirmationaccuracy, accuracynsmoltm, nsmoltmquantitation, quantitationpeptide, peptideiyptngytr, iyptngytrproteolysis, proteolysislcms, lcmsmrm, mrmaverage, averagefab
